Primary Bile Acid Chenodeoxycholic Acid-Based Microcapsules to Examine ß-cell Survival and the Inflammatory Response

In past studies using hydrogel-polyelectrolyte matrix and different bile acid excipients, we microencapsulated pancreatic ß-cells using various methods, and the microcapsules were mechanically stable, displayed good morphological characteristics with good physico-chemical compatibility but had limit...

Full description

Bibliographic Details
Main Authors: Mooranian, A., Negrulj, R., Al-Salami, Hani
Format: Journal Article
Published: Springer 2016
Online Access:http://hdl.handle.net/20.500.11937/19999
_version_ 1848750187250450432
author Mooranian, A.
Negrulj, R.
Al-Salami, Hani
author_facet Mooranian, A.
Negrulj, R.
Al-Salami, Hani
author_sort Mooranian, A.
building Curtin Institutional Repository
collection Online Access
description In past studies using hydrogel-polyelectrolyte matrix and different bile acid excipients, we microencapsulated pancreatic ß-cells using various methods, and the microcapsules were mechanically stable, displayed good morphological characteristics with good physico-chemical compatibility but had limited cell viability and poor cell survival. Using bile acids, cell survival increased but overall remained limited. Thus, this study aimed to test different microencapsulating methods and examine the effects of the primary hydrophobic bile acid, chenodeoxycholic acid (CDCA), on ß-cell microcapsules, in terms of morphology and cell function. Using the polymer sodium alginate (SA) and the co-polymer poly-l-ornithine (PLO), in 10:1 ratio, two microcapsules were made, one without CDCA and one with CDCA. During the microencapsulation process, polymer flow rate and culture media flow rate were screened (0.1–1.5 mL/min) for most uniform microcapsule. Pancreatic ß-cells (NIT-1) were microencapsulated and tested for morphology, formulation physico-chemical compatibility, stability, surface topography and chemical composition. Encapsulated cell viability, metabolism, respiration, bioenergetics, biological activity and the inflammatory profile were also measured. A polymer flow rate of 0.8 mL/min accompanied by 0.6 mL/min media flow rate were found to produce the most uniform microcapsules using 10:1 formulation ratio. The microcapsules showed poor cell viability which was improved significantly after CDCA incorporation. CDCA also enhanced insulin secretion (p < 0.01), metabolism, respiration and bioenergetics (p < 0.01) and significantly reduced the inflammatory response. These benefits were attained without compromising microcapsule size or stability. A polymer flow rate of 0.8 mL/min and a media flow rate of 0.6 mL/min produced good microcapsules when using SA and PLO in 10:1 ratio, and the incorporation of the primary bile acid, chenodeoxycholic acid, enhanced microcapsule stability and significantly increased cell survival and reduced inflammation which suggests potential applications in ß-cell microencapsulation and transplantation.
first_indexed 2025-11-14T07:32:50Z
format Journal Article
id curtin-20.500.11937-19999
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:32:50Z
publishDate 2016
publisher Springer
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-199992017-09-13T13:51:43Z Primary Bile Acid Chenodeoxycholic Acid-Based Microcapsules to Examine ß-cell Survival and the Inflammatory Response Mooranian, A. Negrulj, R. Al-Salami, Hani In past studies using hydrogel-polyelectrolyte matrix and different bile acid excipients, we microencapsulated pancreatic ß-cells using various methods, and the microcapsules were mechanically stable, displayed good morphological characteristics with good physico-chemical compatibility but had limited cell viability and poor cell survival. Using bile acids, cell survival increased but overall remained limited. Thus, this study aimed to test different microencapsulating methods and examine the effects of the primary hydrophobic bile acid, chenodeoxycholic acid (CDCA), on ß-cell microcapsules, in terms of morphology and cell function. Using the polymer sodium alginate (SA) and the co-polymer poly-l-ornithine (PLO), in 10:1 ratio, two microcapsules were made, one without CDCA and one with CDCA. During the microencapsulation process, polymer flow rate and culture media flow rate were screened (0.1–1.5 mL/min) for most uniform microcapsule. Pancreatic ß-cells (NIT-1) were microencapsulated and tested for morphology, formulation physico-chemical compatibility, stability, surface topography and chemical composition. Encapsulated cell viability, metabolism, respiration, bioenergetics, biological activity and the inflammatory profile were also measured. A polymer flow rate of 0.8 mL/min accompanied by 0.6 mL/min media flow rate were found to produce the most uniform microcapsules using 10:1 formulation ratio. The microcapsules showed poor cell viability which was improved significantly after CDCA incorporation. CDCA also enhanced insulin secretion (p < 0.01), metabolism, respiration and bioenergetics (p < 0.01) and significantly reduced the inflammatory response. These benefits were attained without compromising microcapsule size or stability. A polymer flow rate of 0.8 mL/min and a media flow rate of 0.6 mL/min produced good microcapsules when using SA and PLO in 10:1 ratio, and the incorporation of the primary bile acid, chenodeoxycholic acid, enhanced microcapsule stability and significantly increased cell survival and reduced inflammation which suggests potential applications in ß-cell microencapsulation and transplantation. 2016 Journal Article http://hdl.handle.net/20.500.11937/19999 10.1007/s12668-016-0198-9 Springer restricted
spellingShingle Mooranian, A.
Negrulj, R.
Al-Salami, Hani
Primary Bile Acid Chenodeoxycholic Acid-Based Microcapsules to Examine ß-cell Survival and the Inflammatory Response
title Primary Bile Acid Chenodeoxycholic Acid-Based Microcapsules to Examine ß-cell Survival and the Inflammatory Response
title_full Primary Bile Acid Chenodeoxycholic Acid-Based Microcapsules to Examine ß-cell Survival and the Inflammatory Response
title_fullStr Primary Bile Acid Chenodeoxycholic Acid-Based Microcapsules to Examine ß-cell Survival and the Inflammatory Response
title_full_unstemmed Primary Bile Acid Chenodeoxycholic Acid-Based Microcapsules to Examine ß-cell Survival and the Inflammatory Response
title_short Primary Bile Acid Chenodeoxycholic Acid-Based Microcapsules to Examine ß-cell Survival and the Inflammatory Response
title_sort primary bile acid chenodeoxycholic acid-based microcapsules to examine ß-cell survival and the inflammatory response
url http://hdl.handle.net/20.500.11937/19999